Recognizing Thymidine Kinase 2 Deficiency: A CME Activity on Early Diagnosis of a Rare Mitochondrial Myopathy
By
Cristina Domínguez-González, MD
Summary
This educational activity is designed for European neurologists, pediatricians, medical geneticists, and pulmonologists to improve recognition of thymidine kinase 2 deficiency (TK2d), a rare mitochondrial myopathy. The content emphasizes the urgency of early diagnosis and covers the burden of TK2d as well as key clinical features to identify the condition. The article is structured as a continuing medical education (CME) module with learning objectives and disclosures.
Source
Twitter / XRecognizing Thymidine Kinase 2 Deficiency: A CME Activity on Early Diagnosis of a Rare Mitochondrial Myopathymdsc.peKey quotes
· 3 pulledThe goal of this activity is for learners to be better able to recognize possible thymidine kinase 2 deficiency (TK2d) and explain the urgency of early diagnosis.
Upon completion of this activity, participants will: Have increased knowledge regarding the Burden of TK2d
Upon completion of this activity, participants will: Have greater competence related to Identifying the key clinical features of TK2d
You might also wanna read
Emerging therapeutic strategies for mitochondrial DNA-related primary mitochondrial diseases: a review of gene editing, heteroplasmy modulation, and transplantation approaches
This review article by Shi et al. examines emerging therapeutic strategies for mitochondrial DNA (mtDNA)-related primary mitochondrial disea
麦科医药MT1002完成Ib/II期首例入组，卒中“双管线”布局加速推进
JMCR: Clinical Minute
Boston Children's Hospital uses OpenAI's o3 model to diagnose rare genetic diseases in children
Boston Children's Hospital researchers, in collaboration with OpenAI, published a study in NEJM AI demonstrating that off-the-shelf AI tools
nbcnews.com·15d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.